These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. p53 inhibition by the LANA protein of KSHV protects against cell death. Friborg J; Kong W; Hottiger MO; Nabel GJ Nature; 1999 Dec 23-30; 402(6764):889-94. PubMed ID: 10622254 [TBL] [Abstract][Full Text] [Related]
11. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus supports latent DNA replication in dividing cells. Hu J; Garber AC; Renne R J Virol; 2002 Nov; 76(22):11677-87. PubMed ID: 12388727 [TBL] [Abstract][Full Text] [Related]
12. A Screen for Extracellular Signal-Regulated Kinase-Primed Glycogen Synthase Kinase 3 Substrates Identifies the p53 Inhibitor iASPP. Woodard C; Liao G; Goodwin CR; Hu J; Xie Z; Dos Reis TF; Newman R; Rho H; Qian J; Zhu H; Hayward SD J Virol; 2015 Sep; 89(18):9232-41. PubMed ID: 26109723 [TBL] [Abstract][Full Text] [Related]
13. HDM2 antagonist Nutlin-3 disrupts p73-HDM2 binding and enhances p73 function. Lau LM; Nugent JK; Zhao X; Irwin MS Oncogene; 2008 Feb; 27(7):997-1003. PubMed ID: 17700533 [TBL] [Abstract][Full Text] [Related]
14. Identification of Caspase Cleavage Sites in KSHV Latency-Associated Nuclear Antigen and Their Effects on Caspase-Related Host Defense Responses. Davis DA; Naiman NE; Wang V; Shrestha P; Haque M; Hu D; Anagho HA; Carey RF; Davidoff KS; Yarchoan R PLoS Pathog; 2015 Jul; 11(7):e1005064. PubMed ID: 26218605 [TBL] [Abstract][Full Text] [Related]
15. DNA binding and modulation of gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus. Garber AC; Shu MA; Hu J; Renne R J Virol; 2001 Sep; 75(17):7882-92. PubMed ID: 11483733 [TBL] [Abstract][Full Text] [Related]
16. Full-Length Isoforms of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Accumulate in the Cytoplasm of Cells Undergoing the Lytic Cycle of Replication. Garrigues HJ; Howard K; Barcy S; Ikoma M; Moses AV; Deutsch GH; Wu D; Ueda K; Rose TM J Virol; 2017 Dec; 91(24):. PubMed ID: 28978712 [TBL] [Abstract][Full Text] [Related]
17. Reactivation of the p53 pathway as a treatment modality for KSHV-induced lymphomas. Sarek G; Kurki S; Enbäck J; Iotzova G; Haas J; Laakkonen P; Laiho M; Ojala PM J Clin Invest; 2007 Apr; 117(4):1019-28. PubMed ID: 17364023 [TBL] [Abstract][Full Text] [Related]
18. Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts with human myeloid cell nuclear differentiation antigen induced by interferon alpha. Fukushi M; Higuchi M; Oie M; Tetsuka T; Kasolo F; Ichiyama K; Yamamoto N; Katano H; Sata T; Fujii M Virus Genes; 2003 Dec; 27(3):237-47. PubMed ID: 14618084 [TBL] [Abstract][Full Text] [Related]
19. Pathology of Kaposi's Sarcoma-Associated Herpesvirus Infection. Fukumoto H; Kanno T; Hasegawa H; Katano H Front Microbiol; 2011; 2():175. PubMed ID: 21904536 [TBL] [Abstract][Full Text] [Related]
20. Kaposi's sarcoma-associated herpesvirus-encoded LANA can induce chromosomal instability through targeted degradation of the mitotic checkpoint kinase Bub1. Sun Z; Xiao B; Jha HC; Lu J; Banerjee S; Robertson ES J Virol; 2014 Jul; 88(13):7367-78. PubMed ID: 24741095 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]